172 related articles for article (PubMed ID: 15654779)
1. Long-term results of partial splenic artery embolization as supplemental treatment for portal-systemic encephalopathy.
Yoshida H; Mamada Y; Taniai N; Yamamoto K; Kaneko M; Kawano Y; Mizuguchi Y; Kumazaki T; Tajiri T
Am J Gastroenterol; 2005 Jan; 100(1):43-7. PubMed ID: 15654779
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous combined balloon-occluded retrograde transvenous obliteration and partial splenic embolization for portosystemic shunts.
Waguri N; Hayashi M; Yokoo T; Sato R; Arao Y; Setsu T; Sato M; Kohisa J; Hama I; Ohsugi K; Aiba T; Yoneyama O; Furukawa K; Sugimura K; Igarashi K; Suda T
J Vasc Interv Radiol; 2012 May; 23(5):650-7. PubMed ID: 22459878
[TBL] [Abstract][Full Text] [Related]
3. Effect of balloon-occluded retrograde transvenous obliteration on the natural history of coexisting esophageal varices.
Choi YS; Lee JH; Sinn DH; Song YB; Gwak GY; Choi MS; Koh KC; Paik SW; Yoo BC
J Clin Gastroenterol; 2008 Oct; 42(9):974-9. PubMed ID: 18528292
[TBL] [Abstract][Full Text] [Related]
4. Partial splenic embolization for hypersplenism in cirrhosis: a long-term outcome in 62 patients.
Zhu K; Meng X; Qian J; Huang M; Li Z; Guan S; Jiang Z; Shan H
Dig Liver Dis; 2009 Jun; 41(6):411-6. PubMed ID: 19070555
[TBL] [Abstract][Full Text] [Related]
5. Balloon-occluded retrograde transvenous obliteration (BRTO) for a direct shunt between the inferior mesenteric vein and the inferior vena cava in a patient with hepatic encephalopathy.
Ibukuro K; Sugihara T; Tanaka R; Fukuda H; Abe S; Tobe K; Tateishi R; Tagawa K
J Vasc Interv Radiol; 2007 Jan; 18(1 Pt 1):121-5. PubMed ID: 17296712
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic effect of balloon-occluded retrograde transvenous obliteration on portal-systemic encephalopathy in patients with liver cirrhosis.
Kato T; Uematsu T; Nishigaki Y; Sugihara J; Tomita E; Moriwaki H
Intern Med; 2001 Aug; 40(8):688-91. PubMed ID: 11518103
[TBL] [Abstract][Full Text] [Related]
7. Short-term portal hemodynamic effects of partial splenic embolization for hypersplenism.
Chikamori F; Kuniyoshi N; Kawashima T; Takase Y
Hepatogastroenterology; 2007 Sep; 54(78):1847-9. PubMed ID: 18019732
[TBL] [Abstract][Full Text] [Related]
8. [Association of plasma ammonia and GABA levels and the degree of hepatic encephalopathy].
Campollo O; MacGillivray BB; McIntyre N
Rev Invest Clin; 1992; 44(4):483-90. PubMed ID: 1485027
[TBL] [Abstract][Full Text] [Related]
9. Restoration of portal venous perfusion and reversal of encephalopathy by balloon occlusion of portal systemic shunt.
Potts JR; Henderson JM; Millikan WJ; Sones P; Warren WD
Gastroenterology; 1984 Jul; 87(1):208-12. PubMed ID: 6724263
[TBL] [Abstract][Full Text] [Related]
10. [Lactilol (Importal, 10g in powder made by ZYMA) in the treatment of portal systemic encephalopathy].
Boca M; Duris I; Kolibás E; Kratochvíl'ová E
Vnitr Lek; 1996 Apr; 42(4):234-8. PubMed ID: 8693708
[TBL] [Abstract][Full Text] [Related]
11. Partial splenic embolization for cancer patients with thrombocytopenia requiring systemic chemotherapy.
Kauffman CR; Mahvash A; Kopetz S; Wolff RA; Ensor J; Wallace MJ
Cancer; 2008 May; 112(10):2283-8. PubMed ID: 18344210
[TBL] [Abstract][Full Text] [Related]
12. Significant improvement in portal-systemic liver failure symptoms and successful management of portal-splenic venous hemodynamics by the combination of interventional radiology and pharmacotherapy.
Ishikawa T; Hamamoto K; Sasaki R; Nishimura T; Matsuda T; Iwamoto T; Takami T; Sakaida I
Hepatol Res; 2020 Oct; 50(10):1201-1208. PubMed ID: 32609922
[TBL] [Abstract][Full Text] [Related]
13. Portosystemic encephalopathy treated with balloon-occluded retrograde transvenous obliteration.
Kawanaka H; Ohta M; Hashizume M; Tomikawa M; Higashi H; Kishihara F; Sugimachi K; Tokumatsu M
Am J Gastroenterol; 1995 Mar; 90(3):508-10. PubMed ID: 7872302
[No Abstract] [Full Text] [Related]
14. Surgically restoring portal blood flow to the liver in children with primary extrahepatic portal vein thrombosis improves fluid neurocognitive ability.
Mack CL; Zelko FA; Lokar J; Superina R; Alonso EM; Blei AT; Whitington PF
Pediatrics; 2006 Mar; 117(3):e405-12. PubMed ID: 16481447
[TBL] [Abstract][Full Text] [Related]
15. [Successful balloon-occluded retrograde transvenous obliteration (B-RTO) in a case of symptomatic epilepsy with hepatic encephalopathy due to non-cirrhotic porto-systemic shunt].
Shibata A; Hayashi S; Noguchi M
Rinsho Shinkeigaku; 2005 May; 45(5):341-5. PubMed ID: 15960169
[TBL] [Abstract][Full Text] [Related]
16. Partial splenic embolization: 12-month hematological effects and complications.
Wang HY; Shih SC; Lin SC; Chang WS; Wang TE; Lin FJ; Yang FS
Hepatogastroenterology; 2008; 55(86-87):1838-42. PubMed ID: 19102404
[TBL] [Abstract][Full Text] [Related]
17. [Ammoniemia in portosystemic encephalopathy--diagnostic, differential diagnostic and prognostic significance].
Marisavljević D; Golubović M; Tomić D; Krstić M
Srp Arh Celok Lek; 1990; 118(5-6):185-91. PubMed ID: 2075539
[TBL] [Abstract][Full Text] [Related]
18. [Portal-systemic encephalopathy or shunt encephalopathy].
Takeuchi H
Ryoikibetsu Shokogun Shirizu; 2000; (29 Pt 4):129-32. PubMed ID: 11031913
[No Abstract] [Full Text] [Related]
19. Long term results of balloon-occluded retrograde transvenous obliteration for portosystemic shunt encephalopathy in patients with liver cirrhosis and portal hypertension.
Inoue H; Emori K; Toyonaga A; Oho K; Kumamoto M; Haruta T; Mitsuyama K; Tsuruta O; Sata M
Kurume Med J; 2014; 61(1-2):1-8. PubMed ID: 25420513
[TBL] [Abstract][Full Text] [Related]
20. Increased plasma ammonia may inhibit cellular release of branched-chain amino acids in systemic portal encephalopathy.
Jahn HA; Schohn DC; Koehl C; Schmitt RL
Kidney Int Suppl; 1983 Dec; 16():S67-70. PubMed ID: 6588271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
